DiaSorin (DSRLF)
(Delayed Data from OTC)
$107.40 USD
0.00 (0.00%)
Updated Apr 24, 2024 03:54 PM ET
3-Hold of 5 3
C Value D Growth C Momentum C VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 44% (142 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.00 | 1.69 | 9.99 |
Current Quarter Estimate | NA | 5.41 | 60.00 |
Year Ago Quarter Estimate | NA | -1.55 | 52.54 |
Next Quarter Estimate | NA | 5.88 | 61.00 |
Next Year Estimate | 4.79 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | NA | 18.40 | 17.08 |
Next Year | 16.83 | 25.50 | 8.00 |
Last 5 Years | NA | 3.70 | 8.10 |
Next 5 Years | NA | 10.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | 3.67 | 1.94 |
Price/Cash Flow (MRFY) | 11.82 | 10.82 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | 0.17% |
Return on Equity (TTM) | NA | 8.53% |
Debt to Equity (MRQ) | NA | 22.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.